Skip to main content
LUYAN PHARMA CO.,LTD logo

LUYAN PHARMA CO.,LTD — Investor Relations & Filings

Ticker · 002788 ISIN · CNE1000025W1 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,022 across all filing types
Latest filing 2016-04-10 Legal Proceedings Report
Country CN China
Listing Shenzhen Stock Exchange 002788

About LUYAN PHARMA CO.,LTD

https://www.luyan.com.cn

Luyan Pharma Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive logistics network, providing supply chain management services to healthcare institutions, including hospitals and community clinics. Its product portfolio encompasses a wide range of Western pharmaceuticals, traditional Chinese medicines, and medical equipment. In addition to wholesale distribution, the company maintains a significant presence in the retail pharmacy sector through a chain of drugstores. Luyan Pharma focuses on optimizing healthcare delivery through integrated distribution systems and value-added services, such as third-party logistics and pharmaceutical cold chain management. The organization leverages its regional market leadership to expand its service footprint and enhance the efficiency of the medical supply chain.

Recent filings

Filing Released Lang Actions
关于公司子公司收到《立案通知书》的公告
Legal Proceedings Report Classification · 95% confidence The document is a public announcement by a company regarding its subsidiary receiving a formal investigation notice from a regulatory authority (Chengdu Food and Drug Administration). It details the nature of the investigation and references previous disclosures about related issues. The document is short (892 characters) and serves as a regulatory update on legal proceedings rather than a financial report or detailed audit. It does not contain financial statements or management discussion but focuses on legal/regulatory matters. Therefore, it fits best under Legal Proceedings Report (LTR).
2016-04-10 Chinese
第三届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 鹭燕（福建）药业股份有限公司 regarding decisions made at their seventh meeting of the third session. It includes voting results on various proposals such as donations, use of idle raised funds, and internal control standards. The document is an official announcement of meeting resolutions rather than a full report or financial statement. It does not contain financial data or detailed management discussion, nor is it a shareholder meeting voting result announcement. It fits best as a Regulatory Filing (RNS) because it is a formal disclosure of corporate governance actions and decisions that do not fall under other specific categories.
2016-04-06 Chinese
内部控制缺陷认定标准（2016年4月）
Governance Information Classification · 95% confidence The document is titled '内部控制缺陷认定标准' which translates to 'Internal Control Deficiency Identification Standards' for 鹭燕（福建）药业股份有限公司. It outlines definitions, classifications, and standards for identifying internal control deficiencies, including financial and non-financial reporting defects. The content is a detailed internal control policy or standard document rather than a financial report, audit report, or announcement. It does not contain financial statements, audit opinions, or regulatory filings but rather internal governance and control standards. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2016-04-06 Chinese
国信证券股份有限公司关于公司使用部分闲置募集资金暂时补充流动资金的专项核查意见
Regulatory Filings Classification · 95% confidence The document is a special investigation opinion by the sponsor (Guosen Securities Co., Ltd.) regarding the use of part of idle raised funds by Luyan (Fujian) Pharmaceutical Co., Ltd. It references regulatory guidelines related to the management and use of raised funds, details the amount and purpose of the funds, and confirms compliance with relevant rules. The document is a formal verification and opinion letter on the use of raised funds, not a full financial report or earnings release. It is a regulatory compliance-related filing concerning fundraising usage, which fits best under Regulatory Filings (RNS). The document length is short (2174 characters), and it is not an announcement of a report but a standalone opinion letter.
2016-04-06 Chinese
独立董事关于使用部分闲置募集资金暂时补充流动资金的独立意见
Regulatory Filings Classification · 95% confidence The document is a formal independent opinion from the independent directors regarding the company's use of idle raised funds to temporarily supplement working capital. It references compliance with stock exchange listing rules and internal fundraising management systems. The document is short (1200 characters) and consists mainly of an opinion statement and signatures, without financial statements or detailed financial data. It is not a full report but an official statement or opinion related to capital use. This fits best under Regulatory Filings (RNS), as it is a regulatory compliance document and does not constitute a full financial report or announcement of a report publication.
2016-04-06 Chinese
关于使用部分闲置募集资金暂时补充流动资金公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 鹭燕（福建）药业股份有限公司 regarding the temporary use of part of idle raised funds to supplement working capital. It details the amount of funds raised, usage plans, approvals by the board, independent directors, and supervisory board, and compliance with regulatory requirements. The document is relatively short (3829 characters) and focuses on the use of fundraising proceeds rather than presenting financial statements or comprehensive financial data. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a certification or legal proceeding. It is a specific update on capital usage related to fundraising activities, fitting the definition of a Capital/Financing Update (CAP).
2016-04-06 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.